Publications
- Pharmacotherapy of Alzheimer's Disease: Current State and Future Perspectives2014 | Publication without faculty affiliation
- Development of submicromolar 17 beta-HSD10 inhibitors and their in vitro and in vivo evaluation2023 | First Faculty of Medicine
- Recent advances in dopamine D-2 receptor ligands in the treatment of neuropsychiatric disorders2023 | Publication without faculty affiliation
- Strategies for enhanced bioavailability of oxime reactivators in the central nervous system2023 | Publication without faculty affiliation
- Novel D-2/5-HT receptor modulators related to cariprazine with potential implication to schizophrenia treatment2022 | Central Library of Charles University
- Charged pyridinium oximes with thiocarboxamide moiety are equally or less effective reactivators of organophosphate-inhibited cholinesterases compared to analogous carboxamides2022 | Publication without faculty affiliation
- Halogen substituents enhance oxime nucleophilicity for reactivation of cholinesterases inhibited by nerve agents2022 | Publication without faculty affiliation
- Toxicity, pharmacokinetics, and effectiveness of the ortho-chlorinated bispyridinium oxime, K8702022 | Publication without faculty affiliation
- Determination of K869, a Novel Oxime Reactivator of Acetylcholinesterase, in Rat Body Fluids and Tissues by Liquid-Chromatography Methods: Pharmacokinetic Study2021 | Faculty of Pharmacy in Hradec Králové
- Molecular Modeling Studies on the Multistep Reactivation Process of Organophosphate-Inhibited Acetylcholinesterase and Butyrylcholinesterase2021 | Publication without faculty affiliation
Loading network view...